ANTERRA CAPITAL

Thesis

Anterra Capital is a global venture capital firm founded in 2013, with dual headquarters in Amsterdam and Boston, focused on transforming the food and agriculture industry. Their investment thesis centers on building a safe, sustainable, and resilient food system by backing companies leveraging breakthrough biotechnology and digital solutions across the entire food value chain. They target growth-stage founders developing the digital and biological infrastructure of the modern food system, emphasizing a research-driven, thesis-led approach. Key focus areas include biotechnology (crop protection, animal health, food science), digital innovations (digital agriculture, supply chain optimization, data analytics), and sustainable food systems. Anterra Capital has a global mandate, primarily focusing on North America and Europe. They typically act as lead investors in Seed and Series A rounds, with a preference for Series A or B for later-stage investments. The firm also engages in venture creation. Anterra manages over $450 million in AUM, with their second fund closed in 2021 at $225 million and a second Global Food and Agriculture Technology Fund at $260 million. They typically write initial checks ranging from $1 million to $10 million for Seed and Series A rounds, with later-stage investments above €3 million. Anterra Capital was originally a corporate spin-out from Rabobank and is committed to measuring and reporting the impact of its investments alongside financial returns.

Related lists

• Seed-stage Enterprise investors
• Seed-stage Healthcare investors
• Series A Enterprise investors